TTV Viral Load in Heart Transplant Recipients

Active, not recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

March 3, 2022

Primary Completion Date

March 3, 2024

Study Completion Date

March 3, 2024

Conditions
Heart Transplant RejectionHeart Transplant InfectionVirus
Interventions
OTHER

Collection of EDTA blood sample (5 to 7 ml)

"For all the patients included in the study, the samples to measure the viral load will be taken during the transplantation, then at each of the consultations planned as part of the usual care during the first year post-transplant (at minimum once and maximum twice a month).~These samples will be taken at the same time as those taken as part of standard care."

Trial Locations (3)

35033

CHU de Rennes, Rennes

67091

CHU Strasbourg, Strasbourg

75015

Hôpital européen Georges Pompidou, Paris

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

BioMérieux

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER